CGC
Canopy Growth CorporationNASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.64
P/S
0.91
EV/EBITDA
-0.63
DCF Value
$-7.45
FCF Yield
-34.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
24.1%
Operating Margin
-25.5%
Net Margin
-117.3%
ROE
-52.9%
ROA
-29.5%
ROIC
-6.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $74.5M | $-62.6M | $-0.18 |
| Q2 2025 | $66.7M | $-1.6M | $-0.01 |
| Q1 2025 | $72.1M | $-41.5M | $-0.22 |
| Q4 2024 | $65.0M | $-220.8M | $-1.42 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
CA
Exchange
NASDAQ
Beta
2.32
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.